Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China
Haijing Guan, Chunping Wang, Zhigang Zhao, Sheng Han
Topics & Concepts
MedicineHepatocellular carcinomaInternal medicineChinaRheumatologyOncologyCarcinomaLawPolitical scienceHepatocellular Carcinoma Treatment and PrognosisHealth Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer